Demand still strong for India-made AstraZeneca vaccine doses – COVAX’s GAVI
By Krishna N. Das NEW DELHI (Reuters) – Global vaccine-sharing network COVAX is still seeing strong demand for India-made doses of the AstraZeneca COVID-19 shot, one of its backers GAVI said, following comments from producer the Serum Institute of India (SII) that uptake had slowed sharply. The SII, the world’s biggest vaccine maker, told India’s …
Demand still strong for India-made AstraZeneca vaccine doses – COVAX’s GAVI Read More »